ENPP7 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FAM151A | Family with sequence similarity 151, member A | | | | | | Group enriched |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
ISX | Intestine-specific homeobox | Transcription factors
| | | | | Group enriched |
ITLN1 | Intelectin 1 (galactofuranose binding) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Group enriched |
LCT | Lactase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
LINC00955 | Long intergenic non-protein coding RNA 955 | Predicted membrane proteins
| | | | | Group enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
MYO1A | Myosin IA | Disease related genes Plasma proteins
| | | | | Group enriched |
MYRFL | Myelin regulatory factor-like | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | | | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
RBP2 | Retinol binding protein 2, cellular | Transporters
| | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |